- Home
- TLSI vs NATR Comparison
TLSI vs NATR Comparison
Compare TLSI & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | NATR |
|---|---|---|
| Founded | 2010 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.2M | 250.0M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TLSI | NATR |
|---|---|---|
| Price | $5.08 | $14.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $28.33 |
| AVG Volume (30 Days) | 153.0K | ★ 234.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.00 |
| EPS | N/A | ★ 0.48 |
| Revenue | $45,151,000.00 | ★ $480,144,000.00 |
| Revenue This Year | $35.45 | $7.76 |
| Revenue Next Year | $37.58 | $4.82 |
| P/E Ratio | ★ N/A | $28.73 |
| Revenue Growth | ★ 53.41 | 5.67 |
| 52 Week Low | $2.20 | $12.97 |
| 52 Week High | $7.95 | $28.14 |
Technical Indicators
Market Signals| Indicator | TLSI | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 25.49 |
| Support Level | $4.21 | $13.72 |
| Resistance Level | $5.58 | $21.27 |
| Average True Range (ATR) | 0.30 | 0.42 |
| MACD | -0.06 | 0.13 |
| Stochastic Oscillator | 28.73 | 5.26 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.